Exemplos de uso de Primary insomnia em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Along with bouts of hypomania and primary insomnia.
Addition", which is rarer among individuals with primary insomnia, implies recreational use, ingestion of high doses, long-term use, etc.
Other important finding was the relationship of general hyperalgesia in patients with primary insomnia.
Strategies for the treatment of primary insomnia involve sleep hygiene routines, behavioral techniques, and/or pharmacological treatment.
The European Union approved a prolonged release of 2 milligrams of melatonin for the treatment of primary insomnia characterized by a bad quality of sleep.
The use of medications to sleep for the treatment of primary insomnia may lead to side effects that include drowsiness and fatigue on the first hours of the morning.
The effects of Circadin have also been studied in three main studies involving a total of 681 patients aged over 55 years with primary insomnia.
Circadin is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
Circadin has been compared with placebo(a dummy treatment) in three main studies involving a total of 681 patients aged over 55 years with primary insomnia.
It must be emphasized that the factors related to the stress which may contribute to the appearance of primary insomnia are usually not taken into account when the patient seeks medical assistance.
Because of the role of melatonin in sleep and circadian rhythm regulation, and the age related decrease in endogenous melatonin production,melatonin may effectively improve sleep quality particularly in patients who are over 55 with primary insomnia.
The author analyzed the use of benzodiazepines for the treatment of primary insomnia, alerting that the adverse effect during the administration of this medications include the drowsiness and the fatigue during the first hours of the morning.
However, as few doctors are aware of it, it often goes untreated oris treated inappropriately; DSPD is often misdiagnosed as primary insomnia or as a psychiatric condition.
Circadin is used as monotherapy for the short-term treatment of primary insomnia(difficulty in getting to sleep or staying asleep, or poor quality of sleep for at least one month), characterised by poor quality of sleep in patients aged 55 years and older.
However, since many doctors are unfamiliar with the condition, it often goes untreated oris treated inappropriately; DSPD is often misdiagnosed as primary insomnia or as a psychiatric condition.
Circadin is used on its own for the short-term treatment of primary insomnia(poor quality of sleep) in patients aged 55 years or over.‘ Primary' means that the insomnia does not have any identified cause, including other medical, mental or environmental causes.
Objective: to evaluate the chronic effect of resistance exercise with moderate intensity, and stretching exercise in subjective sleep complaints, sleep pattern and the clinical variables related to state anxiety, memory complaints, attention, mood andquality of life in patients with chronic primary insomnia.
According to Monti 2000,most cases of primary insomnia that with an etiology not related to another mental disorder, medical condition, or chemical dependency, may be induced by stressful situations, such as the distancing of a family member, loss of employment, economic difficulty, surgical intervention, etc.
Adler emphasized that antipsychotics, as well as antidepressants, are essential for the treatment of sleep disorders accompanying some well-defined psychiatric disorders. However, the author also stated that these drugs,especially antidepressants, could be used as a second-line medication in the treatment of primary insomnia.
However, researches that sought to investigate the relationship between primary insomnia and executive functioning were quite inconsistent from a methodological point of view, especially in regard to the variability of the used methods, the heterogeneity of diagnostic criteria for insomnia and the control of sleep altering drugs.
The Committee for Medicinal Products for Human Use(CHMP) decided that, although Circadin has been shown to have a small effect size in a relatively small fraction of patients,its benefits are greater than its risks for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
Smith et al. suggested that the association of primary insomnia and hyperalgesia at a nonorofacial site suggests that primary insomnia may be linked with central sensitivity and could play an etiologic role in idiopathic pain disorders, therefore, sleep disturbances are also considered an important risk indicator for the development of TMD.
In clinical trials, where patients suffering from primary insomnia received Circadin 2 mg every evening for 3 weeks, benefits were shown in treated patients compared to placebo in sleep latency(as measured by objective and subjective means) and in subjective quality of sleep and daytime functioning(restorative sleep) with no impairment of vigilance during the day.
Materials and methods: twenty-eight sedentary adults(22 women and6 men) with chronic primary insomnia, with an average age of 42.61 years, divided into 3 groups: resistance exercise group- reg(n=10), stretching group- sg(n=10) and control group- cg(n=8) participated in a randomized controlled trial, lasting four months of resistance exercise protocol and stretching exercises, performed three times a week.
In summary, antipsychotics are not the medication of choice in the treatment of primary chronic insomnia.
Based on the results of the polysomnography results, the patients were categorized as belonging to one of the following groups:psychophysiological or idiopathic insomnia; primary snoring; and OSAHS.
Patients with mental impairment were excluded, as were those who were shift workers,as well as those presenting polysomnographic findings suggestive of disorders other than OSAHS, insomnia or primary snoring.